| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Top7 or 10 Tips > The Top Ten Failures We Make as Employees |
|
Digg It - The Top Ten Failures We Make as Employees
I often write articles critical or at least challenging of management of organisations. But of course, it is not only managers who behave in such a way as to cause problems. Often it is me, the subordinate employee. Her According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product e are my top ten failures I observe of employees, like us.
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in othing about the answers. I do not seek and secure a job that has at least some of the elements of the answers. I miss the opportunity to shine in a job that I will enjoy and thereby advance my career and remuneration. lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. questionsThe boss asks me to do something. I leave their office not understanding what they really wanted. Or I leave the office thinking I know exactly what they wanted. In either case I did not ask a clarifying question. What is here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe he end result? The majority of times I deliver something back which requires a major revision or is completely off track. The reason I did not ask questions in the first place is some misplaced view about how competent I might be seen if I ask cl d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro arifying questions. Returning time and again with work which requires revision, leaves people in no doubt about my competence. ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc o a question which requires a factual answer. I either make a best guess or I pick an answer I have a vague recollection of from another conversation I had with another colleague. "I don't know, but I'll find out", is an answer I find difficult easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi to say; even though coming back within a short time with a more considered answer saves time and rework. nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically I continually manage upwards. I make sure that they get no bad news. I even go to the level of burying bad numbers in a sea of detail. Or I am economical with my definition of some variables I need to report on so that they appear better than the and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ y are. I do this to the detriment of the business; because the boss does not want to hear bad news, or so I have convinced myself. ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi e with a sentence commencing with,"We can't because..." I am being incredibly lazy. What I need to do is ask a clarifying question to be sure I heard right and then say, "We can if..." ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a poor sales figures and explain them away due to "poor sales skills"; instead of being specific and saying, "Poor opening skills" or "Poor product knowledge", or "Poor closing skills". When I am not specific and I talk about a generic solution li dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod e "Sales training" for the above example, I risk applying a generic solution to a generic problem. Generic solutions applied to generic opportunities get a completely random result. cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ive late for meetings. I even make a bit of a joke out of it. I can't determine the difference between urgent and important tasks, proactive and reactive tasks. I call meetings which do not have a purpose. I cc people on emails I send because the tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen y might like to know. I complain of being overworked, spending many hours in the office over the norm. t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel targets and therefore I think I deserve a large bonus. In fact, when I meet my targets; I fulfil the requirements of my job. If I always meet my targets, I am likely to be promoted to a more challenging role with a higher salary. If I exceed my ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust targets by a wide margin, then I may deserve a bonus. y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ole. That is their problem. They have a job to do just as I do and they just have to cope with what I do to meet my targets. Or constantly I am aware of the big picture, changing what I do and what my department does to help out. Whatever it tak . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de es to get the big picture right is my motto. I don't get the day-to-day detail done. My customers suffer. My colleagues suffer waiting for my work. Our organisation suffers. elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip le are either for me or against me. People must earn my respect. I have no respect for people with whom I disagree. I do not seek the common ground on which we do agree so that we may have respect for each other, even through disagreements. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:What if Finding a Good High Paying Job Were Too Easy? Networking Groups - Try To Attend Even When You're Moonlighting Selling; Stop Telling and Start Listening
|